Industry News
-
Mass General Brigham-Led Consortium Wins ARPA-H Award to Advance On-Demand Manufacturing of Genetic Medicines
Sep 08 2026 -
Bristol Myers Reports Phase 2 Success for GPRC5D-Directed CAR-T in Relapsed/Refractory Multiple Myeloma
Sep 08 2026 -
Early Phase 1 Results for BAFF-R-Targeted CAR T Show Durable Complete Responses in R/R B-Cell Lymphoma, Including After Prior CD19 CAR-T Failure
Sep 08 2026 -
Base-Editing Study Reports Durable Clinical Benefits in Sickle Cell Disease and Beta-Thalassemia Across Diverse Genetic Backgrounds
Sep 07 2026 -
uniQure Submits FDA Application for AAV Gene Therapy AMT-130, Seeking First Approved Treatment for Huntington’s Disease
Sep 02 2026 -
New Approach Streamlines Stem Cell Collection for Sickle Cell Gene Therapy in First-in-Human Trial
Aug 25 2026 -
Cellenkos Receives FDA Fast Track Designation for Cord Blood-Derived Treg Cell Therapy in ALS
Aug 25 2026 -
Mahzi Therapeutics Receives FDA Rare Pediatric Disease Designation for AAV9 Gene Therapy in Pitt Hopkins Syndrome
Aug 25 2026 -
Rznomics Joins Lilly Gateway Labs to Advance RNA-Based Gene Therapies
Aug 24 2026